Clinical Trial Update: Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma [Phase 3]

View source ↗

Summary

Phase 3 study assessing tezepelumab's effect on immune response to influenza vaccination in adults with moderate to severe asthma has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Moderate to Severe Asthma | Phase 3 | Status: COMPLETED | Results posted: 2023-04-21